Your browser doesn't support javascript.
loading
Randomized phase 2 trial of ixazomib and dexamethasone in relapsed multiple myeloma not refractory to bortezomib.
Kumar, Shaji K; LaPlant, Betsy R; Reeder, Craig B; Roy, Vivek; Halvorson, Alese E; Buadi, Francis; Gertz, Morie A; Bergsagel, P Leif; Dispenzieri, Angela; Thompson, Melanie A; Crawley, Jamie; Kapoor, Prashant; Mikhael, Joseph; Stewart, Keith; Hayman, Suzanne R; Hwa, Yi L; Gonsalves, Wilson; Witzig, Thomas E; Ailawadhi, Sikander; Dingli, David; Go, Ronald S; Lin, Yi; Rivera, Candido E; Rajkumar, S Vincent; Lacy, Martha Q.
Afiliação
  • Kumar SK; Division of Hematology and.
  • LaPlant BR; Department of Biostatistics, Mayo Clinic. Rochester, MN.
  • Reeder CB; Division of Hematology and Oncology, Mayo Clinic, Scottsdale, AZ; and.
  • Roy V; Division of Hematology and Oncology, Mayo Clinic, Jacksonville, FL.
  • Halvorson AE; Department of Biostatistics, Mayo Clinic. Rochester, MN.
  • Buadi F; Division of Hematology and.
  • Gertz MA; Division of Hematology and.
  • Bergsagel PL; Division of Hematology and Oncology, Mayo Clinic, Scottsdale, AZ; and.
  • Dispenzieri A; Division of Hematology and.
  • Thompson MA; Division of Hematology and.
  • Crawley J; Division of Hematology and.
  • Kapoor P; Division of Hematology and.
  • Mikhael J; Division of Hematology and Oncology, Mayo Clinic, Scottsdale, AZ; and.
  • Stewart K; Division of Hematology and Oncology, Mayo Clinic, Scottsdale, AZ; and.
  • Hayman SR; Division of Hematology and.
  • Hwa YL; Division of Hematology and.
  • Gonsalves W; Division of Hematology and.
  • Witzig TE; Division of Hematology and.
  • Ailawadhi S; Division of Hematology and Oncology, Mayo Clinic, Jacksonville, FL.
  • Dingli D; Division of Hematology and.
  • Go RS; Division of Hematology and.
  • Lin Y; Division of Hematology and.
  • Rivera CE; Division of Hematology and Oncology, Mayo Clinic, Jacksonville, FL.
  • Rajkumar SV; Division of Hematology and.
  • Lacy MQ; Division of Hematology and.
Blood ; 128(20): 2415-2422, 2016 11 17.
Article em En | MEDLINE | ID: mdl-27702799
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Compostos de Boro / Dexametasona / Protocolos de Quimioterapia Combinada Antineoplásica / Resistencia a Medicamentos Antineoplásicos / Bortezomib / Glicina / Mieloma Múltiplo / Recidiva Local de Neoplasia Tipo de estudo: Clinical_trials Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Compostos de Boro / Dexametasona / Protocolos de Quimioterapia Combinada Antineoplásica / Resistencia a Medicamentos Antineoplásicos / Bortezomib / Glicina / Mieloma Múltiplo / Recidiva Local de Neoplasia Tipo de estudo: Clinical_trials Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article